Kleiner Perkins is lining up a new $400M tech fund
Legendary Silicon Valley venture group Kleiner Perkins Caufield & Byers — a player in the biotech arena — has outlined plans to raise $400 million for a new fund in a filing yesterday with the SEC.
That number may well just be a place holder for the final figure. CNBC reported a few weeks ago that Kleiner Perkins was raising two funds for a total of about $1.3 billion, quoting sources. About $800 million of that was being reserved for more mature companies while the rest would be startup oriented.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.